Disseminated thrombosis in COVID-19 Cases: The role of early antithrombotic treatments?

0Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Many newly published articles have focused on the association between COVID-19 and thrombogenicity. Indeed, it has become a frequently observed phenomena. In this study, we report on a 45-year-old man with a COVID-19-positive test. His dramatic progression started 5 days after admission. He developed a right ventricular (RV) thrombus (rare condition) and multiple brain sites infarction. We discuss this phenomena by showing the extent to which the thrombosis can take place, the possible relation between inflammatory, D-dimer and case progression and suggest a treatment approach particularly in cases with multiple thrombogenicity organ involvement.

Cite

CITATION STYLE

APA

Alhashmi, J. M., Elhoufi, A. M., Elhatou, E., & Ghanaim, M. (2021). Disseminated thrombosis in COVID-19 Cases: The role of early antithrombotic treatments? Dubai Medical Journal, 4(1), 26–30. https://doi.org/10.1159/000509906

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free